Phathom Pharmaceuticals, Inc. financial data

Symbol
PHAT on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Campus Drive,, Suite 102, Florham Park, NJ
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 728 % -20%
Quick Ratio 4.09 %
Debt-to-equity -330 % +44.2%
Return On Equity 211 % -50.7%
Return On Assets -91.9 % -5.26%
Operating Margin -1.1K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 68.4M shares +19.4%
Common Stock, Shares, Outstanding 68.3M shares +20.3%
Entity Public Float 526M USD +166%
Common Stock, Value, Issued 6K USD +20%
Weighted Average Number of Shares Outstanding, Basic 64.6M shares +13.8%
Weighted Average Number of Shares Outstanding, Diluted 64.6M shares +13.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 26.3M USD
Cost of Revenue 4.33M USD
Research and Development Expense 38.9M USD -25.9%
General and Administrative Expense 91.6M USD +2.05%
Operating Income (Loss) -288M USD -99.8%
Nonoperating Income (Expense) -51.5M USD -56.2%
Net Income (Loss) Attributable to Parent -339M USD -91.7%
Earnings Per Share, Basic -5.74 USD/shares -50.3%
Earnings Per Share, Diluted -5.74 USD/shares -50.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 335M USD +56.6%
Inventory, Net 3.11M USD +2703%
Assets, Current 374M USD +64.9%
Property, Plant and Equipment, Net 1.66M USD -16.2%
Operating Lease, Right-of-Use Asset 833K USD -50.5%
Other Assets, Noncurrent 1.69M USD -54.9%
Assets 387M USD +63.3%
Accounts Payable, Current 7.13M USD +23.1%
Accrued Liabilities, Current 35.8M USD +166%
Contract with Customer, Liability, Current 20.2M USD +745%
Liabilities, Current 65.3M USD +172%
Contract with Customer, Liability, Noncurrent 322M USD +161%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 10.8M USD +43.3%
Liabilities 574M USD +125%
Retained Earnings (Accumulated Deficit) -1.19B USD -40%
Stockholders' Equity Attributable to Parent -187M USD -953%
Liabilities and Equity 387M USD +63.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -69M USD -74%
Net Cash Provided by (Used in) Financing Activities 9.9M USD -29.6%
Net Cash Provided by (Used in) Investing Activities -40K USD +81.3%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 68.3M shares +20.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -59.2M USD -129%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.74M USD +46.9%
Deferred Tax Assets, Valuation Allowance 176M USD +39.4%
Deferred Tax Assets, Gross 176M USD +39.2%
Operating Lease, Liability 680K USD -49.6%
Depreciation 500K USD -2.72%
Payments to Acquire Property, Plant, and Equipment 40K USD -81.3%
Lessee, Operating Lease, Liability, to be Paid 703K USD -51.6%
Property, Plant and Equipment, Gross 4.3M USD +12.1%
Operating Lease, Liability, Current 680K USD -5.69%
Lessee, Operating Lease, Liability, to be Paid, Year Two 513K USD -31.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 513K USD -31.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 23K USD -77.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 513K USD -3.03%
Deferred Tax Assets, Operating Loss Carryforwards 120M USD +39.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 40M shares 0%
Unrecognized Tax Benefits 3.01M USD +29.4%
Operating Lease, Payments 200K USD 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 214K USD +46.6%
Deferred Tax Assets, Net of Valuation Allowance 343K USD -28.7%
Share-based Payment Arrangement, Expense 41.9M USD +54.8%
Interest Expense 58.1M USD +54%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%